Doctors Note Logo

Published on: 10/27/2026

Pediatric Naproxen: Juvenile Arthritis Formulations vs. Adult OTC Tablets

Prescription naproxen for juvenile idiopathic arthritis is dosed by body weight, usually about 10 to 15 mg/kg per day split into two doses and often given as a 125 mg/5 mL oral suspension for accurate measuring, whereas adult OTC naproxen sodium 220 mg tablets are labeled only for ages 12 and older and for short-term use of a few days. The two products also differ in salt form, onset, strength per dose, and duration of therapy, which is why an OTC tablet is not a simple substitute for a child's arthritis regimen. Long-term pediatric use requires clinician oversight for stomach, kidney, liver, and blood pressure effects, plus awareness of pseudoporphyria, a scarring rash seen more often in fair-skinned children taking naproxen. Dosing caps, formulation swaps, and timing details matter, so review the complete answer below before changing anything. If your child has ongoing joint pain, swelling, morning stiffness, or you are unsure whether current symptoms need urgent attention, a free, instant, online symptom check can help you organize what you are seeing and decide on sensible next steps.

Last reviewed for medical accuracy: 10/27/2026

answer background

Concerned about your symptoms?

Explanation

Pediatric Naproxen: Juvenile Arthritis Formulations vs. Adult OTC Tablets

Parents often ask about prescription naproxen vs OTC Aleve for a child, especially when a child has juvenile idiopathic arthritis (JIA) or another painful inflammatory condition. Although both products contain naproxen or a closely related naproxen salt, they are not automatically interchangeable. The correct choice depends on the child’s age, weight, diagnosis, other medicines, and the exact product label.

Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). It can reduce pain, swelling, stiffness, and fever. It is sometimes prescribed for juvenile arthritis, but children should not be given adult-strength naproxen products without guidance from a doctor or pharmacist.

What is the difference between prescription naproxen and OTC Aleve?

Prescription naproxen and OTC Aleve are both NSAIDs, but they may differ in strength, formulation, and approved use.

Prescription naproxen

Prescription products may include:

  • Naproxen tablets
  • Naproxen sodium tablets
  • Liquid oral suspension
  • Other formulations depending on the country and manufacturer

For children with juvenile idiopathic arthritis, a liquid suspension can be especially useful because the dose can be measured according to the child’s weight. This may be easier and more accurate than splitting an adult tablet.

The U.S. prescription labeling for naproxen includes pediatric dosing for juvenile arthritis. A commonly used labeled dose is based on body weight—approximately 10 mg per kilogram per day, divided into two doses. However, the prescribing doctor must calculate the actual dose and decide whether this medicine is appropriate. The dose may not be suitable for every child, particularly children with kidney problems, dehydration, stomach ulcers, bleeding disorders, or certain medication allergies.

OTC Aleve

Aleve is a brand name for an over-the-counter form of naproxen sodium. In the United States, one standard Aleve tablet generally contains 220 mg of naproxen sodium, which is equivalent to about 200 mg of naproxen.

OTC Aleve labeling is intended primarily for adults and children aged 12 years and older. Children under 12 should not be given OTC Aleve unless a healthcare professional specifically recommends it. Even for teenagers, the OTC adult directions may not be appropriate when the medicine is being used for juvenile arthritis, persistent joint swelling, or another chronic condition.

The key issue is that an adult OTC dose is not the same as a pediatric, weight-based prescription dose. Giving “one tablet” because it seems convenient can result in too much medicine for a smaller child—or too little treatment for a child who needs a carefully planned anti-inflammatory regimen.

Why liquid naproxen may be preferred for juvenile arthritis

Juvenile arthritis treatment often continues for weeks or months and requires regular medical follow-up. A prescription liquid may offer several advantages:

  • Weight-based dosing: The amount can be adjusted as the child grows.
  • More accurate dosing: A doctor or pharmacist can prescribe a specific volume, measured with an oral syringe.
  • Easier swallowing: This can help children who cannot safely swallow tablets.
  • More consistent treatment: A scheduled prescription may be more appropriate for ongoing inflammation than occasional OTC use.

Not every child with juvenile arthritis needs naproxen, and naproxen alone may not control the disease. JIA can require disease-modifying medicines, physical therapy, injections, or other treatments prescribed by a pediatrician or pediatric rheumatologist. Naproxen helps symptoms but does not necessarily prevent long-term joint damage.

Can a child take an adult Aleve tablet instead?

Sometimes a doctor may recommend an OTC naproxen product for an older child or teenager. However, parents should not make that substitution on their own.

Before using adult OTC Aleve, ask a healthcare professional to confirm:

  • The child’s age and weight
  • The exact product and strength
  • Whether the condition is appropriate for self-treatment
  • How often the medicine should be given
  • The maximum daily amount
  • Whether the child is taking other medicines
  • Whether the child has asthma, kidney disease, stomach problems, or medication allergies

It is also important to check whether the product contains naproxen sodium, naproxen, or another pain-relieving ingredient. Different strengths and formulations should not be assumed to be equivalent simply because they have similar names.

Important safety precautions

Naproxen can irritate the stomach and, in some cases, cause ulcers or gastrointestinal bleeding. It can also affect kidney function, especially when a child is dehydrated from vomiting, diarrhea, fever, or poor fluid intake.

Do not give naproxen without medical advice if the child:

  • Has had an allergic reaction to naproxen, ibuprofen, aspirin, or another NSAID
  • Has a history of stomach ulcers or gastrointestinal bleeding
  • Has kidney disease, significant liver disease, or heart problems
  • Is dehydrated or unable to keep fluids down
  • Has been told to avoid NSAIDs
  • Is scheduled for surgery
  • Takes blood thinners, steroids, lithium, methotrexate, certain blood-pressure medicines, or other regular medicines

Do not combine naproxen with ibuprofen, aspirin used for pain, or another NSAID unless a clinician specifically instructs you to do so. Combining NSAIDs does not usually provide better relief and can increase the risk of side effects. Acetaminophen is a different type of pain reliever, but it should still be used according to the child’s age, weight, and medical advice.

Give naproxen with food or milk if recommended by the child’s healthcare professional. This may reduce stomach upset, although it does not eliminate the risk of bleeding. Use the measuring device supplied with a liquid medicine rather than a household teaspoon.

When to seek medical help

Stop the medicine and seek prompt medical advice if a child develops:

  • Severe or persistent stomach pain
  • Vomiting blood or material that looks like coffee grounds
  • Black or bloody stools
  • Facial swelling, hives, wheezing, or trouble breathing
  • Very little urination, unusual swelling, or extreme tiredness
  • A widespread rash, blistering, or peeling skin
  • Symptoms that are getting worse despite treatment

Speak to a doctor about any serious, sudden, or potentially life-threatening symptoms rather than relying on an online checker or home treatment. Seek emergency help for breathing difficulty, collapse, severe allergic symptoms, major bleeding, confusion, or severe dehydration.

For less urgent concerns, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help organize symptoms and suggest what type of care may be appropriate, but it cannot replace an examination or a prescribed treatment plan.

Bottom line

When comparing prescription naproxen vs OTC Aleve for a child, the main differences are not just the brand name. Prescription naproxen may provide a liquid formulation and a carefully calculated, weight-based dose for juvenile arthritis. OTC Aleve is generally labeled for adults and children aged 12 and older and is not automatically suitable for younger children or chronic inflammatory disease.

Use the product specifically recommended by the child’s doctor or pharmacist. Do not substitute adult OTC tablets for a prescription liquid or tablet without confirming the dose and safety first. If the child has ongoing joint swelling, morning stiffness, repeated pain, or reduced movement, speak to a doctor or pediatric rheumatologist so the underlying condition can be properly assessed and treated.

(References)

  • * Mäkelä AL. Naproxen in the treatment of juvenile rheumatoid arthritis. Metabolism, safety and efficacy. Scand J Rheumatol. 1977;6(4):193-205. doi: 10.3109/03009747709095449. PMID: 343231.

  • * Stiehm ER. Nonsteroidal anti-inflammatory drugs in pediatric patients. Am J Dis Child. 1988 Dec;142(12):1281-2. doi: 10.1001/archpedi.1988.02150120035032. PMID: 3195526.

  • * Sterling JC, Pye RJ. Naproxen-induced pseudoporphyria. Br J Rheumatol. 1987 Jun;26(3):210-1. doi: 10.1093/rheumatology/26.3.210. PMID: 3580714.

  • * Kvien TK, Høyeraal HM, Sandstad B. Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study. Scand J Rheumatol. 1984;13(4):342-50. doi: 10.3109/03009748409111307. PMID: 6395321.

  • * De Silva B, Banney L, Uttley W, Luqmani R, Schofield O. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. Pediatr Dermatol. 2000 Nov-Dec;17(6):480-3. doi: 10.1046/j.1525-1470.2000.01827.x. PMID: 11123786.

  • * Verma S, Gupta R, Lodha R, Kabra SK. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA). Indian Pediatr. 2009 Mar;46(3):264-5. PMID: 19346579.

  • * Mondal R, Das A, Gayen G, Banerjee D. Familial Juvenile Idiopathic Arthritis. Indian J Pediatr. 2017 May;84(5):408-409. doi: 10.1007/s12098-016-2283-z. Epub 2017 Jan 11. PMID: 28074316.

  • * Sá MC, Moreira C, Melo C, Sousa Á, Carvalho S. Lyme disease and juvenile idiopathic arthritis - A pediatric case report. Rev Bras Reumatol Engl Ed. 2017 Nov-Dec;57(6):620-622. doi: 10.1016/j.rbre.2015.09.006. Epub 2015 Dec 11. PMID: 29173699.

  • * Brutzkus JC, Shahrokhi M, Varacallo MA. Naproxen. 2023 Jan. PMID: 30247840.

  • * Au SCL. Understanding network meta-analysis. World J Clin Cases. 2024 Dec 16;12(35):6848-6850. doi: 10.12998/wjcc.v12.i35.6848. PMID: 39687645; PMCID: PMC11525911.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.